Diseases, Conditions, Syndromes

Experimental COVID-19 vaccine prevents severe disease in mice

An experimental vaccine is effective at preventing pneumonia in mice infected with the COVID-19 virus, according to a study from Washington University School of Medicine in St. Louis. The vaccine, which is made from a mild ...

Vaccination

Russia's race for virus vaccine raises concerns in the West

Russia boasts that it's about to become the first country to approve a COVID-19 vaccine, with mass vaccinations planned as early as October using shots that are yet to complete clinical trials—and scientists worldwide are ...

Diseases, Conditions, Syndromes

Virus vaccine put to final test in thousands of volunteers

The world's biggest COVID-19 vaccine study got underway Monday with the first of 30,000 planned volunteers helping to test shots created by the U.S. government—one of several candidates in the final stretch of the global ...

Vaccination

Experimental COVID-19 vaccine safe, generates immune response

An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well tolerated and prompted neutralizing antibody activity in healthy ...

Diseases, Conditions, Syndromes

Brazil to help test Oxford coronavirus vaccine

An experimental vaccine against the new coronavirus developed at the University of Oxford will be tested from mid-June in Brazil, the first country outside Britain to take part in the study, researchers said Wednesday.

Diseases, Conditions, Syndromes

As US, Europe reopen more, big nations see rising virus toll

American car makers are getting back to work and Europe is continuing to reopen. But while new coronavirus cases have been declining in many countries that were initially hit hard by the pandemic, cases are rapidly rising ...

Diseases, Conditions, Syndromes

Moderna: Early coronavirus vaccine results are encouraging

An experimental vaccine against the coronavirus showed encouraging results in very early testing, triggering hoped-for immune responses in eight healthy, middle-aged volunteers, its maker a project called "Operation Warp ...

page 5 from 18